文字起こし 🔗
1
00:00:00,000 --> 00:00:01,590
(gentle music)
2
00:00:01,590 --> 00:00:03,025
- This is "Engenuity",
3
00:00:03,025 --> 00:00:05,430
a Boilermaker Engineering Podcast.
4
00:00:05,430 --> 00:00:07,770
This episode discusses pharmaceuticals
5
00:00:07,770 --> 00:00:09,663
from discovery to delivery.
6
00:00:10,500 --> 00:00:12,330
- Welcome to the "Engenuity Podcast",
7
00:00:12,330 --> 00:00:14,220
featuring some of the latest inspiring
8
00:00:14,220 --> 00:00:16,740
and innovative stories
from Purdue Engineering.
9
00:00:16,740 --> 00:00:19,590
I'm Arvind Raman, Boilermaker alumnus
10
00:00:19,590 --> 00:00:21,003
and Dean of Engineering.
11
00:00:22,080 --> 00:00:25,320
These days it seems every week or so
12
00:00:25,320 --> 00:00:28,473
we hear of a new wonder
drug hitting the market,
13
00:00:29,310 --> 00:00:33,000
and we might well marvel
at how small molecules
14
00:00:33,000 --> 00:00:35,160
or biologics are discovered
15
00:00:35,160 --> 00:00:38,280
to provide life-changing treatments.
16
00:00:38,280 --> 00:00:40,890
However, there's a lot more to the story
17
00:00:40,890 --> 00:00:43,410
of wonder drugs than the
research breakthroughs
18
00:00:43,410 --> 00:00:46,980
and preclinical and clinical
trials that enable them.
19
00:00:46,980 --> 00:00:49,200
Just because you can manufacture something
20
00:00:49,200 --> 00:00:51,090
on a tabletop in a lab
21
00:00:51,090 --> 00:00:54,180
does not mean that you
can make it at scale
22
00:00:54,180 --> 00:00:56,640
as a deliverable product.
23
00:00:56,640 --> 00:01:00,870
Productization, packaging,
quality assurance,
24
00:01:00,870 --> 00:01:04,560
delivery, and meeting
stringent regulations
25
00:01:04,560 --> 00:01:08,100
are all challenging issues
that must be addressed
26
00:01:08,100 --> 00:01:10,080
so the new drug can be approved
27
00:01:10,080 --> 00:01:14,430
and its benefits actually
realized across society.
28
00:01:14,430 --> 00:01:17,970
Now, this is a core Purdue
competency now centered
29
00:01:17,970 --> 00:01:20,820
at its New Young Institute.
30
00:01:20,820 --> 00:01:22,260
The institute was established
31
00:01:22,260 --> 00:01:24,600
through a generous donation from a pioneer
32
00:01:24,600 --> 00:01:26,880
in pharmaceutical and
biotechnology manufacturing,
33
00:01:26,880 --> 00:01:28,950
William D. Young.
34
00:01:28,950 --> 00:01:31,740
The Purdue Chemical Engineering
alumnus was a pioneer
35
00:01:31,740 --> 00:01:34,920
in recombinant DNA based biotechnology
36
00:01:34,920 --> 00:01:38,073
and is well known for
his work at Genentech.
37
00:01:39,120 --> 00:01:41,790
The Young Institute makes
a lot of sense in Indiana
38
00:01:41,790 --> 00:01:44,550
because manufacturing and
packaging pharmaceuticals
39
00:01:44,550 --> 00:01:47,640
are also a core Indiana strength.
40
00:01:47,640 --> 00:01:51,510
Indiana leads the United States
in pharmaceutical exports.
41
00:01:51,510 --> 00:01:53,490
It has been one of the top three states
42
00:01:53,490 --> 00:01:56,520
and exports for all life sciences products
43
00:01:56,520 --> 00:01:58,590
for more than a decade.
44
00:01:58,590 --> 00:02:01,230
That heritage goes back a long way.
45
00:02:01,230 --> 00:02:04,470
In 1923, Eli Lilly and Company
46
00:02:04,470 --> 00:02:07,080
became the first to mass produce insulin
47
00:02:07,080 --> 00:02:09,330
for patients with diabetes.
48
00:02:09,330 --> 00:02:11,580
Now, today it is our great pleasure
49
00:02:11,580 --> 00:02:13,800
to welcome two Purdue experts
50
00:02:13,800 --> 00:02:16,710
on pharma and biotechnology
to "Engenuity".
51
00:02:16,710 --> 00:02:18,600
First, Elizabeth Topp,
52
00:02:18,600 --> 00:02:20,910
Professor of Industrial
and Molecular Pharmaceutics
53
00:02:20,910 --> 00:02:22,740
and Chemical Engineering at Purdue.
54
00:02:22,740 --> 00:02:24,360
Dr. Topp is the Director
55
00:02:24,360 --> 00:02:27,870
of the William D. and
Sherry L. Young Institute
56
00:02:27,870 --> 00:02:31,350
for the Advanced Manufacturing
of Pharmaceuticals at Purdue.
57
00:02:31,350 --> 00:02:35,670
Dr. Topp previously served as
the Chief Scientific Officer
58
00:02:35,670 --> 00:02:38,790
at the National Institute
for Bioprocessing
59
00:02:38,790 --> 00:02:43,170
Research and Training,
NIBRT, in Dublin, Ireland,
60
00:02:43,170 --> 00:02:44,640
and internationally recognized
61
00:02:44,640 --> 00:02:46,020
R&D training organization
62
00:02:46,020 --> 00:02:47,370
focused on driving the growth
63
00:02:47,370 --> 00:02:51,420
of the biopharmaceutical
manufacturing industry in Ireland,
64
00:02:51,420 --> 00:02:54,900
with striking parallels
to what is taking place
65
00:02:54,900 --> 00:02:56,283
today in Indiana.
66
00:02:57,210 --> 00:03:00,450
Also joining us today
is Dr. Alina Alexeenko,
67
00:03:00,450 --> 00:03:01,860
Professor of Chemical Engineering
68
00:03:01,860 --> 00:03:04,470
and Professor of Aeronautics
and Astronautics.
69
00:03:04,470 --> 00:03:07,920
Recently also served as
a Senior Associate Dean
70
00:03:07,920 --> 00:03:09,030
for Undergrad Education
71
00:03:09,030 --> 00:03:11,520
and Academic Programs in Indianapolis.
72
00:03:11,520 --> 00:03:13,680
Dr. Alexeenko is also the President
73
00:03:13,680 --> 00:03:15,540
and Co-Founder of LyoWave,
74
00:03:15,540 --> 00:03:18,570
a high tech startup that is
commercializing technology
75
00:03:18,570 --> 00:03:20,580
developed here at Purdue
76
00:03:20,580 --> 00:03:23,250
to advance pharmaceuticals manufacturing.
77
00:03:23,250 --> 00:03:26,247
Welcome Drs. Topp and
Alexeenko to "Engenuity."
78
00:03:27,120 --> 00:03:27,953
- Thank you, Arvind.
79
00:03:27,953 --> 00:03:29,400
- Thank you.
80
00:03:29,400 --> 00:03:34,380
- Well, let's begin today's
podcast with a few questions.
81
00:03:34,380 --> 00:03:36,090
Let me start with a
question to both of you
82
00:03:36,090 --> 00:03:37,890
and you know, please feel free
83
00:03:37,890 --> 00:03:40,320
to answer in any sequence that you want.
84
00:03:40,320 -->
Load full transcript
00:03:43,710
Can you provide our
listeners, if you will,
85
00:03:43,710 --> 00:03:45,690
a map of how a new drug
86
00:03:45,690 --> 00:03:48,120
gets to the market in the first place,
87
00:03:48,120 --> 00:03:49,470
starting from its discovery?
88
00:03:49,470 --> 00:03:51,720
How does that process work?
89
00:03:51,720 --> 00:03:54,090
- Yes, it's a really
interesting road, Arvind,
90
00:03:54,090 --> 00:03:55,530
and I'm glad that you asked.
91
00:03:55,530 --> 00:04:00,270
So sometimes we think that once
you've found a new molecule,
92
00:04:00,270 --> 00:04:02,340
say that's going to treat Alzheimer's
93
00:04:02,340 --> 00:04:05,760
or some other neurological
disease, that that's it.
94
00:04:05,760 --> 00:04:07,440
That we have a new discovery
95
00:04:07,440 --> 00:04:10,080
and we can simply start
administering it to patients.
96
00:04:10,080 --> 00:04:12,720
But of course, the drug first has
97
00:04:12,720 --> 00:04:15,101
to go from being effective
in the laboratory
98
00:04:15,101 --> 00:04:17,670
to being effective in patients.
99
00:04:17,670 --> 00:04:19,740
And so we have to first figure out whether
100
00:04:19,740 --> 00:04:21,750
that drug not only works in lab rats,
101
00:04:21,750 --> 00:04:24,810
but also works in humans
and clinical trials.
102
00:04:24,810 --> 00:04:28,140
And we often can't predict
what the side effect profile
103
00:04:28,140 --> 00:04:30,870
of the drug is going to be ahead of
104
00:04:30,870 --> 00:04:32,220
clinical trials and patients.
105
00:04:32,220 --> 00:04:34,380
And if those side effects are rare,
106
00:04:34,380 --> 00:04:35,566
we have to look at a lot of patients
107
00:04:35,566 --> 00:04:39,060
before we can determine what
those side effects will be.
108
00:04:39,060 --> 00:04:40,620
And then we have to move from the place
109
00:04:40,620 --> 00:04:42,930
that we have an effective drug
110
00:04:42,930 --> 00:04:45,750
to making a formulation of the drug
111
00:04:45,750 --> 00:04:47,520
and then manufacturing the drug.
112
00:04:47,520 --> 00:04:51,000
So you may know that when
you take a pharmaceutical,
113
00:04:51,000 --> 00:04:54,120
when you take, let's say
acetaminophen for a headache,
114
00:04:54,120 --> 00:04:55,920
you're not just taking acetaminophen,
115
00:04:55,920 --> 00:04:58,830
it's been formulated
with binders and fillers,
116
00:04:58,830 --> 00:05:01,740
and that tablet or capsule has been coded.
117
00:05:01,740 --> 00:05:04,110
So the thing that you're
taking is not just drug,
118
00:05:04,110 --> 00:05:06,090
it's drug plus other things
119
00:05:06,090 --> 00:05:08,190
that are part of the formulation.
120
00:05:08,190 --> 00:05:10,110
And then once we have that
all sorted out, of course,
121
00:05:10,110 --> 00:05:12,090
we have to figure out
how to manufacture it.
122
00:05:12,090 --> 00:05:15,120
And that's what Alina and I
are especially interested in.
123
00:05:15,120 --> 00:05:18,120
How do we manufacture
these pharmaceuticals
124
00:05:18,120 --> 00:05:20,520
more effectively, more efficiently
125
00:05:20,520 --> 00:05:22,290
so that we can keep the cost low
126
00:05:22,290 --> 00:05:24,990
and be able to make them
available to patients.
127
00:05:24,990 --> 00:05:26,370
- All right, now that's great, thank you.
128
00:05:26,370 --> 00:05:31,370
Now to what extent is
this particular phase
129
00:05:31,530 --> 00:05:33,300
that you're talking about formulation
130
00:05:33,300 --> 00:05:36,450
and manufacturing effectively, low cost.
131
00:05:36,450 --> 00:05:38,670
Like how much is that a barrier
132
00:05:38,670 --> 00:05:41,250
to bringing drugs into the market today?
133
00:05:41,250 --> 00:05:42,713
- It's a really interesting question
134
00:05:42,713 --> 00:05:45,090
and maybe Alina you can weigh in to that,
135
00:05:45,090 --> 00:05:47,190
we often think of
discovery as the barrier,
136
00:05:47,190 --> 00:05:49,170
finding the new molecule is the thing,
137
00:05:49,170 --> 00:05:51,060
but pharmaceuticals themselves are
138
00:05:51,060 --> 00:05:53,580
what I'd like to call low volume
139
00:05:53,580 --> 00:05:54,960
compared to some of the other things
140
00:05:54,960 --> 00:05:56,850
in the chemical process industry,
141
00:05:56,850 --> 00:05:58,950
high value added.
142
00:05:58,950 --> 00:06:02,430
So these are not necessarily
expensive starting materials,
143
00:06:02,430 --> 00:06:04,740
but the products can be quite expensive
144
00:06:04,740 --> 00:06:07,470
and highly regulated materials.
145
00:06:07,470 --> 00:06:11,220
And so the barrier to
getting them to the patient
146
00:06:11,220 --> 00:06:15,510
is not necessarily the
manufacturing process per se,
147
00:06:15,510 --> 00:06:18,390
but a lot of the quality
and regulatory things
148
00:06:18,390 --> 00:06:20,490
that wrap around manufacturing.
149
00:06:20,490 --> 00:06:22,320
Maybe Alina, you can weigh in too.
150
00:06:22,320 --> 00:06:23,280
- So there are several,
151
00:06:23,280 --> 00:06:24,720
maybe in addition to barriers,
152
00:06:24,720 --> 00:06:27,660
there are several bumps on the road
153
00:06:27,660 --> 00:06:31,530
from discovery to actual patients.
154
00:06:31,530 --> 00:06:34,363
And so just to give some examples is that
155
00:06:34,363 --> 00:06:36,960
a typical biopharmaceutical
156
00:06:36,960 --> 00:06:39,930
or more broadly injectable
pharmaceuticals,
157
00:06:39,930 --> 00:06:44,010
they are first manufactured
in one location
158
00:06:44,010 --> 00:06:45,630
as a drug substance,
159
00:06:45,630 --> 00:06:48,960
either, you know, grown
in cells or synthesized,
160
00:06:48,960 --> 00:06:52,650
and that typically
involves producing batches
161
00:06:52,650 --> 00:06:55,353
that are on a kilogram scale.
162
00:06:56,490 --> 00:07:00,753
But the actual drug product,
which will be that packaged,
163
00:07:01,830 --> 00:07:04,080
the miracle drug delivered to patients
164
00:07:04,080 --> 00:07:07,773
to actually do something good,
165
00:07:08,760 --> 00:07:10,330
that would
involve milligrams
166
00:07:11,220 --> 00:07:14,460
of that initial drug substance.
167
00:07:14,460 --> 00:07:17,010
And there is lots of bumps on that road.
168
00:07:17,010 --> 00:07:20,430
Drug substance may be manufactured
in much fewer locations
169
00:07:20,430 --> 00:07:21,263
around the world,
170
00:07:21,263 --> 00:07:26,010
especially early in the
lifetime of a drug product
171
00:07:26,010 --> 00:07:29,580
when it's still going through approvals,
172
00:07:29,580 --> 00:07:30,413
- Trials, and all that.
173
00:07:30,413 --> 00:07:33,543
- It may be manufactured only,
say in Chicago, Illinois,
174
00:07:34,530 --> 00:07:38,193
and then it moves to patients
which are all over the world.
175
00:07:39,540 --> 00:07:44,280
And that typically takes
weeks and and years, right.
176
00:07:44,280 --> 00:07:46,710
And so drug substance often needs
177
00:07:46,710 --> 00:07:48,510
to be preserved during that time.
178
00:07:48,510 --> 00:07:53,040
So this magic molecule
Liz calls it diva often,
179
00:07:53,040 --> 00:07:55,380
it has to be kept happy
during all of this.
180
00:07:55,380 --> 00:08:00,030
So, and just as a
mechanical engineer term,
181
00:08:00,030 --> 00:08:02,893
often involves creating a
very special conditions.
182
00:08:02,893 --> 00:08:06,450
So I would say that some of the most
183
00:08:06,450 --> 00:08:08,580
difficult bumps on that road
184
00:08:08,580 --> 00:08:13,230
and that road may involve
going on a highway on truck
185
00:08:13,230 --> 00:08:14,063
with all the bumps there.
186
00:08:14,063 --> 00:08:15,300
- Oh, right literal bumps.
187
00:08:15,300 --> 00:08:18,540
- Literal bumps or, and the
stresses that are involved.
188
00:08:18,540 --> 00:08:19,398
- Yeah.
189
00:08:19,398 --> 00:08:22,950
- Or going over across
the ocean on airplane.
190
00:08:22,950 --> 00:08:23,783
- Yeah.
191
00:08:23,783 --> 00:08:26,100
- Right, so I would say
stability and sterility
192
00:08:26,100 --> 00:08:28,020
are the most difficult pieces.
193
00:08:28,020 --> 00:08:30,870
So stability is usually
addressed by freezing
194
00:08:30,870 --> 00:08:32,280
and keeping things very cold.
195
00:08:32,280 --> 00:08:35,610
Drug substance is mostly
shaped within the cold chain,
196
00:08:35,610 --> 00:08:37,230
often ultra cold,
197
00:08:37,230 --> 00:08:40,140
and then sterility, the drug product,
198
00:08:40,140 --> 00:08:42,240
some of those new pharmaceuticals
199
00:08:42,240 --> 00:08:43,680
that are really life changing,
200
00:08:43,680 --> 00:08:45,480
lifesaving and life changing,
201
00:08:45,480 --> 00:08:46,773
they're all injectables.
202
00:08:47,700 --> 00:08:49,890
And so they have to be
manufactured in this space,
203
00:08:49,890 --> 00:08:52,600
like extremely clean environment
204
00:08:53,970 --> 00:08:56,550
to avoid any kinds of contamination.
205
00:08:56,550 --> 00:08:57,963
And that's another bump.
206
00:08:58,830 --> 00:08:59,967
- You might sometimes say,
207
00:08:59,967 --> 00:09:02,047
and your listeners might think,
208
00:09:02,047 --> 00:09:03,930
"Well, gosh, all these smart people
209
00:09:03,930 --> 00:09:05,460
are inventing drug molecules,
210
00:09:05,460 --> 00:09:08,430
why can't they invent
stable drug molecules?"
211
00:09:08,430 --> 00:09:11,010
And I think an interesting
thing about pharmaceuticals
212
00:09:11,010 --> 00:09:13,530
is that they're inherently unstable.
213
00:09:13,530 --> 00:09:17,310
We don't want them to bind
to a receptor in the body
214
00:09:17,310 --> 00:09:19,292
and never turn off.
215
00:09:19,292 --> 00:09:22,770
We like them to do their job
and then degrade and go away,
216
00:09:22,770 --> 00:09:25,500
and we'd like them to not
contaminate the environment
217
00:09:25,500 --> 00:09:27,180
when they're finished doing their work
218
00:09:27,180 --> 00:09:28,590
to prevent disease in us.
219
00:09:28,590 --> 00:09:31,620
And so they're an
inherently stable molecules.
220
00:09:31,620 --> 00:09:33,720
Like flowers bloom and then go away.
221
00:09:33,720 --> 00:09:36,000
Drug molecules do their job,
222
00:09:36,000 --> 00:09:39,439
but then we'd like them to
disappear back into the atoms
223
00:09:39,439 --> 00:09:41,610
that made them up in the first place.
224
00:09:41,610 --> 00:09:43,980
And so we want them to be unstable,
225
00:09:43,980 --> 00:09:46,680
but we have to deal with the
fact that they're unstable.
226
00:09:46,680 --> 00:09:50,910
- Wow, so somehow it's
about programmed stability
227
00:09:50,910 --> 00:09:52,320
or instability, if you will.
228
00:09:52,320 --> 00:09:54,180
That's really fascinating.
229
00:09:54,180 --> 00:09:58,169
- In a sense it's like pressing
the pause button on time,
230
00:09:58,169 --> 00:09:59,683
and then fast forwarding it.
231
00:09:59,683 --> 00:10:02,700
- Right, and then just playing
whenever it's ready to go.
232
00:10:02,700 --> 00:10:04,587
Now that's really amazing.
233
00:10:04,587 --> 00:10:07,470
And so it's fascinating that,
234
00:10:07,470 --> 00:10:08,700
you know, the Young Institute,
235
00:10:08,700 --> 00:10:12,060
both of you are pioneers in that field.
236
00:10:12,060 --> 00:10:13,740
There is a question that comes up
237
00:10:13,740 --> 00:10:15,630
as you think of scale up of yield,
238
00:10:15,630 --> 00:10:17,490
you know what's the acceptable yield,
239
00:10:17,490 --> 00:10:19,796
the amount of correctly
produced doses, right.
240
00:10:19,796 --> 00:10:22,890
To what extent is that a measure
241
00:10:22,890 --> 00:10:26,740
in addition to stability of the viability
242
00:10:26,740 --> 00:10:29,190
of a drug manufacturing process?
243
00:10:29,190 --> 00:10:31,830
Like is that a key metric
that the industry uses?
244
00:10:31,830 --> 00:10:34,050
- Alina, I know we'll have
a lot to say about this,
245
00:10:34,050 --> 00:10:35,610
but I'll I'll say a few words first
246
00:10:35,610 --> 00:10:38,010
before turning it over to her.
247
00:10:38,010 --> 00:10:41,400
It used to be when the
cost of pharmaceuticals
248
00:10:41,400 --> 00:10:43,980
starting materials was very low,
249
00:10:43,980 --> 00:10:46,440
that ensuring that we had high quality
250
00:10:46,440 --> 00:10:48,030
of the materials going to patients
251
00:10:48,030 --> 00:10:52,020
was much more important
than tossing out tablets
252
00:10:52,020 --> 00:10:54,510
or capsules that really didn't meet spec.
253
00:10:54,510 --> 00:10:55,890
But now as the materials
254
00:10:55,890 --> 00:10:57,540
that are going into our drug products
255
00:10:57,540 --> 00:11:00,000
are becoming increasingly expensive,
256
00:11:00,000 --> 00:11:03,330
that kind of low yield
is no longer acceptable.
257
00:11:03,330 --> 00:11:05,730
And Alina, I know you have
a lot to say about this
258
00:11:05,730 --> 00:11:07,500
in the drug product side.
259
00:11:07,500 --> 00:11:11,710
- Yeah, just to add that kind
of every step on that road
260
00:11:13,020 --> 00:11:16,320
includes some loss.
261
00:11:16,320 --> 00:11:20,280
And so, and there is some loss
waste time due to stability,
262
00:11:20,280 --> 00:11:24,090
instability, degradation,
physical, chemical.
263
00:11:24,090 --> 00:11:27,180
And especially as we want to
264
00:11:27,180 --> 00:11:30,300
increase throughput, manufacture more,
265
00:11:30,300 --> 00:11:33,750
we often have to resort
to a very different,
266
00:11:33,750 --> 00:11:35,580
even different different physics,
267
00:11:35,580 --> 00:11:38,580
much higher feel volumes,
268
00:11:38,580 --> 00:11:42,600
which even from fluid
dynamics would take us
269
00:11:42,600 --> 00:11:46,290
to a very different flow regime.
270
00:11:46,290 --> 00:11:48,210
- So the science is not
straightforward at all-
271
00:11:48,210 --> 00:11:50,610
- The science is not straightforward.
272
00:11:50,610 --> 00:11:52,170
Multiplying by a 100
273
00:11:52,170 --> 00:11:54,090
may take you to a very different physics.
274
00:11:54,090 --> 00:11:54,923
- Right, right.
275
00:11:54,923 --> 00:11:56,607
Now, this is absolutely fascinating.
276
00:11:56,607 --> 00:12:00,964
- And there's an interesting
regulatory interface too.
277
00:12:00,964 --> 00:12:04,290
Historically the way that we've approved
278
00:12:04,290 --> 00:12:08,340
or qualified lots of drug coming
off the manufacturing line
279
00:12:08,340 --> 00:12:12,420
is to statistically sample
the tablets or capsules
280
00:12:12,420 --> 00:12:15,390
that are coming off and evaluate them.
281
00:12:15,390 --> 00:12:18,630
So a small sample of the
large lot is evaluated
282
00:12:18,630 --> 00:12:19,890
and then as an indicator
283
00:12:19,890 --> 00:12:22,500
of the quality of the lot as a whole,
284
00:12:22,500 --> 00:12:24,090
and then what happens after that is,
285
00:12:24,090 --> 00:12:27,720
if those samples are
deemed to be unacceptable,
286
00:12:27,720 --> 00:12:29,520
the whole lot is discarded.
287
00:12:29,520 --> 00:12:30,353
- Right.
- And so-
288
00:12:30,353 --> 00:12:32,064
- This is the quality assurance
side effect requires that.
289
00:12:32,064 --> 00:12:34,590
- And so thousands and thousands of vials
290
00:12:34,590 --> 00:12:37,140
may be discarded because
the statistical sample
291
00:12:37,140 --> 00:12:38,460
was not acceptable.
292
00:12:38,460 --> 00:12:41,940
And it may very well be that
90% of the lot was fine.
293
00:12:41,940 --> 00:12:45,510
And so this is a regulatory framework.
294
00:12:45,510 --> 00:12:47,250
It's part of the regulatory framework
295
00:12:47,250 --> 00:12:48,990
of how we look at pharmaceuticals.
296
00:12:48,990 --> 00:12:51,960
And so you can imagine if we
could shift to a framework
297
00:12:51,960 --> 00:12:54,570
that enabled us to evaluate
each file separately-
298
00:12:54,570 --> 00:12:55,403
- Sure, sure.
299
00:12:55,403 --> 00:12:57,810
- Then the yields might be
higher in our overall production.
300
00:12:57,810 --> 00:13:00,600
- Well, and that could potentially lead to
301
00:13:00,600 --> 00:13:02,100
not just increases in production,
302
00:13:02,100 --> 00:13:05,670
but lowering costs, you know,
production costs and stuff.
303
00:13:05,670 --> 00:13:07,110
Well, this is interesting, you know,
304
00:13:07,110 --> 00:13:10,230
to hear about the
bottlenecks and challenges.
305
00:13:10,230 --> 00:13:12,300
It's literally about the last mile.
306
00:13:12,300 --> 00:13:13,740
The patient is waiting,
307
00:13:13,740 --> 00:13:15,150
there are many bumps on the road,
308
00:13:15,150 --> 00:13:18,630
and you're all helping
solve those key problems.
309
00:13:18,630 --> 00:13:21,600
Dr. Alexeenko, I'll kind
of switch to a question
310
00:13:21,600 --> 00:13:26,130
related to your work as
co-founder of LyoWave,
311
00:13:26,130 --> 00:13:29,310
which is intended or trying
to tackle some of these kind
312
00:13:29,310 --> 00:13:31,740
of challenges and really
move the state of the art.
313
00:13:31,740 --> 00:13:33,390
Can you tell us what you're up to
314
00:13:33,390 --> 00:13:36,870
with this pretty high
tech startup you've got?
315
00:13:36,870 --> 00:13:37,920
- Yeah, thank you.
316
00:13:37,920 --> 00:13:42,040
So what we're doing at
LyoWave is aiming at
317
00:13:42,900 --> 00:13:45,420
electrifying pharmaceutical manufacturing,
318
00:13:45,420 --> 00:13:47,970
a particular focus on cold chain.
319
00:13:47,970 --> 00:13:49,352
Those bumps that I mentioned,
320
00:13:49,352 --> 00:13:52,740
the ultra cold storage limitations,
321
00:13:52,740 --> 00:13:54,690
and in general,
322
00:13:54,690 --> 00:13:59,100
replacing some of the
traditional operations,
323
00:13:59,100 --> 00:14:01,413
unit process operations in
pharmaceutical manufacturing
324
00:14:01,413 --> 00:14:04,530
with the much more energy
efficient versions.
325
00:14:04,530 --> 00:14:08,310
So we are focusing first
specifically on lyophilization.
326
00:14:08,310 --> 00:14:12,240
You mentioned that now there
is almost like every week
327
00:14:12,240 --> 00:14:14,670
there is a new drug in the news.
328
00:14:14,670 --> 00:14:18,240
There is actually every
week there is one new
329
00:14:18,240 --> 00:14:20,070
lyophilized drug product approved.
330
00:14:20,070 --> 00:14:21,880
So there is 40 to 50 new
331
00:14:22,740 --> 00:14:25,380
FDA approved lyophilized drug products
332
00:14:25,380 --> 00:14:28,440
approved every year for
the past couple of years.
333
00:14:28,440 --> 00:14:29,850
If you look 20 years ago,
334
00:14:29,850 --> 00:14:32,073
that was happening only once a quarter.
335
00:14:33,210 --> 00:14:38,210
But there is currently not
enough of worldwide capacity
336
00:14:38,430 --> 00:14:42,690
to manufacture as many
pharmaceuticals in lyophilized forms
337
00:14:42,690 --> 00:14:46,230
so that they can be shipped
outside of cold chain.
338
00:14:46,230 --> 00:14:47,220
So that, for example,
339
00:14:47,220 --> 00:14:48,820
if a global emergency happens,
340
00:14:48,820 --> 00:14:51,183
there is enough of a stockpile vaccine.
341
00:14:52,650 --> 00:14:54,900
And so that's exactly
what we're addressing.
342
00:14:54,900 --> 00:14:56,130
And the way we're doing it,
343
00:14:56,130 --> 00:14:58,970
we're replacing a traditional
heat transfer process,
344
00:14:58,970 --> 00:15:02,280
which involves fluid flow
through stainless steel
345
00:15:02,280 --> 00:15:05,400
and then heat transfer
through a vacuum gap
346
00:15:05,400 --> 00:15:07,350
which is a good thermal insulator,
347
00:15:07,350 --> 00:15:12,180
with electromagnetic
technology with microwaves,
348
00:15:12,180 --> 00:15:13,350
but in a very special way.
349
00:15:13,350 --> 00:15:16,470
So if you look at your, you
know, microwave in the kitchen,
350
00:15:16,470 --> 00:15:19,500
you can heat water pretty fast.
351
00:15:19,500 --> 00:15:22,320
If you want to say, de-freeze your turkey,
352
00:15:22,320 --> 00:15:24,420
first of all you can't put
the turkey in the microwave
353
00:15:24,420 --> 00:15:26,194
often it's not the right size.
354
00:15:26,194 --> 00:15:27,027
- It depends on the size.
355
00:15:27,027 --> 00:15:28,440
- Yeah, it depends on the size.
356
00:15:28,440 --> 00:15:31,140
Oftentimes it's just,
357
00:15:31,140 --> 00:15:33,450
it's also there is a
cold spots and hotspot.
358
00:15:33,450 --> 00:15:36,030
So what we're doing,
359
00:15:36,030 --> 00:15:38,790
based on the innovations at Purdue
360
00:15:38,790 --> 00:15:41,257
we're developing much higher frequency
361
00:15:42,330 --> 00:15:44,250
microwave heating sources
362
00:15:44,250 --> 00:15:47,160
that operate at about 1/10 of a power
363
00:15:47,160 --> 00:15:48,930
of a kitchen microwave.
364
00:15:48,930 --> 00:15:50,760
The higher frequency is very important
365
00:15:50,760 --> 00:15:52,380
because it's the right frequency
366
00:15:52,380 --> 00:15:55,200
for putting energy into a cold,
367
00:15:55,200 --> 00:15:57,990
either a drug substance
or frozen drug product
368
00:15:57,990 --> 00:15:59,220
that is being lyophilized
369
00:15:59,220 --> 00:16:00,990
and it also decreases the size
370
00:16:00,990 --> 00:16:03,900
of the
hot spots or cold spots.
371
00:16:03,900 --> 00:16:06,660
So remember that turntable
in the microwave oven,
372
00:16:06,660 --> 00:16:11,100
we don't need it because we
came up with ways to turn
373
00:16:11,100 --> 00:16:13,413
and move around electromagnetic field.
374
00:16:13,413 --> 00:16:14,994
- Waw, that's amazing, that's amazing.
375
00:16:14,994 --> 00:16:18,780
- So that's our kind of our focus at the-
376
00:16:18,780 --> 00:16:21,300
- So if I were to understand correctly,
377
00:16:21,300 --> 00:16:23,040
so I understand that a lot of biologics,
378
00:16:23,040 --> 00:16:26,520
a lot of molecules need like
storage at low temperatures,
379
00:16:26,520 --> 00:16:30,180
but this potentially
bypasses that completely,
380
00:16:30,180 --> 00:16:33,690
is the difference between
having orange juice
381
00:16:33,690 --> 00:16:35,520
that you might buy in, you know,
382
00:16:35,520 --> 00:16:38,310
that's all from a cold chain
in your supermarket store
383
00:16:38,310 --> 00:16:41,070
to just buying packets of certain things
384
00:16:41,070 --> 00:16:42,930
that you can distribute without
385
00:16:42,930 --> 00:16:46,230
and potentially take it to
remote parts of the world
386
00:16:46,230 --> 00:16:48,300
where there is no electricity, right,
387
00:16:48,300 --> 00:16:50,067
to keep things cold anymore, right.
388
00:16:50,067 --> 00:16:52,320
- And and maybe a better analogy, Arvind,
389
00:16:52,320 --> 00:16:54,930
is it's not the difference
between orange juice
390
00:16:54,930 --> 00:16:56,100
and frozen orange juice,
391
00:16:56,100 --> 00:16:58,110
but it's the difference
between strawberries
392
00:16:58,110 --> 00:17:00,810
and frozen strawberries and
freeze-dried strawberries.
393
00:17:00,810 --> 00:17:01,850
- And freeze-dried strawberries, exactly.
394
00:17:01,850 --> 00:17:03,720
- So the freeze-dried strawberries
395
00:17:03,720 --> 00:17:05,160
don't need to be in the freezer
396
00:17:05,160 --> 00:17:06,900
in order to be shipped around the world.
397
00:17:06,900 --> 00:17:07,733
- Right.
398
00:17:07,733 --> 00:17:09,900
- They're part of your
breakfast cereal boxes.
399
00:17:09,900 --> 00:17:12,570
And so they're more stable
400
00:17:12,570 --> 00:17:14,550
in that the water's
been removed from them,
401
00:17:14,550 --> 00:17:16,110
but they don't have to be stored
402
00:17:16,110 --> 00:17:17,769
at those very cold temperatures.
403
00:17:17,769 --> 00:17:18,810
- Got it, got it.
404
00:17:18,810 --> 00:17:21,390
So this is really making it accessible.
405
00:17:21,390 --> 00:17:23,520
I mean, the process really makes a drug
406
00:17:23,520 --> 00:17:26,040
accessible to millions and millions
407
00:17:26,040 --> 00:17:27,330
of people worldwide, right?
408
00:17:27,330 --> 00:17:30,873
- Example of that is a smallpox vaccine,
409
00:17:31,980 --> 00:17:34,727
which the global eradication of smallpox
410
00:17:34,727 --> 00:17:37,560
which to this day is
the only human disease
411
00:17:37,560 --> 00:17:40,200
completely eradicated by vaccination
412
00:17:40,200 --> 00:17:42,870
only happened when there was a lyophilized
413
00:17:42,870 --> 00:17:45,663
thermally stable vaccine developed
414
00:17:45,663 --> 00:17:50,663
that could remain active for
30 days at hot temperatures.
415
00:17:50,970 --> 00:17:54,060
So when it's in a pocket
of healthcare workers
416
00:17:54,060 --> 00:17:56,250
somewhere out there in Africa
417
00:17:56,250 --> 00:17:59,220
trying to make it the
last mile to the patient.
418
00:17:59,220 --> 00:18:00,053
- Wow!
- And...
419
00:18:00,900 --> 00:18:02,550
- So the next time a global pandemic hits,
420
00:18:02,550 --> 00:18:05,940
it could well be a lyophilized
drug that saves the world.
421
00:18:05,940 --> 00:18:08,640
- I wanna just emphasize what it is Alina
422
00:18:08,640 --> 00:18:10,440
and her group are doing with LyoWave.
423
00:18:10,440 --> 00:18:12,690
Because we've had
lyophilization for a while.
424
00:18:12,690 --> 00:18:15,810
You have freeze-dried strawberries
in your breakfast cereal,
425
00:18:15,810 --> 00:18:19,350
but lyophilization of
pharmaceuticals can be slow
426
00:18:19,350 --> 00:18:21,450
and very energy inefficient.
427
00:18:21,450 --> 00:18:24,390
So a typical lyophilization
process can take
428
00:18:24,390 --> 00:18:26,280
a week to run a batch.
429
00:18:26,280 --> 00:18:30,204
And so what Alina and LyoWave
are doing is they're using
430
00:18:30,204 --> 00:18:35,204
microwaves to speed up the
drying part of freeze-drying
431
00:18:35,490 --> 00:18:38,736
so that we shorten the
cycle times, cut the cost
432
00:18:38,736 --> 00:18:42,210
of doing lyophilization while
still turning out this great
433
00:18:42,210 --> 00:18:44,970
stable product that the
worker can put in her pocket.
434
00:18:44,970 --> 00:18:47,760
- Yeah, the most energy
intensive part of that process.
435
00:18:47,760 --> 00:18:49,950
This is fantastic, fantastic.
436
00:18:49,950 --> 00:18:54,120
Dr. Topp, please tell us
something about the New Institute,
437
00:18:54,120 --> 00:18:55,860
the Young Institute at Purdue.
438
00:18:55,860 --> 00:18:59,130
it's mission programs,
partners and so forth,
439
00:18:59,130 --> 00:19:02,220
and what's your vision for the program?
440
00:19:02,220 --> 00:19:03,780
- Well, we're so excited to have
441
00:19:03,780 --> 00:19:05,097
the young institute here at Purdue
442
00:19:05,097 --> 00:19:08,400
and to have it named for
Bill and Sherry Young.
443
00:19:08,400 --> 00:19:11,580
And you mentioned earlier
in the podcast that
444
00:19:11,580 --> 00:19:15,690
Bill was very instrumental
in the biologics revolution,
445
00:19:15,690 --> 00:19:17,190
and you also mentioned insulin.
446
00:19:17,190 --> 00:19:19,620
Well, I wanna connect
those two dots first.
447
00:19:19,620 --> 00:19:23,010
So you may know that here in Indiana,
448
00:19:23,010 --> 00:19:25,800
before we had recombinant DNA technology,
449
00:19:25,800 --> 00:19:28,890
we, Eli Lilly, made insulin for
patients,
450
00:19:28,890 --> 00:19:30,900
and they made insulin for patients
451
00:19:30,900 --> 00:19:35,900
by isolating the pancreas's
of pigs and other animals,
452
00:19:36,870 --> 00:19:39,660
pigs and cows, grinding them up
453
00:19:39,660 --> 00:19:42,840
in a kind of meat processing kind of way,
454
00:19:42,840 --> 00:19:44,640
isolating the insulin
455
00:19:44,640 --> 00:19:47,400
and administering those
insulins to patients.
456
00:19:47,400 --> 00:19:52,400
So patients received
porcine and bovine insulin.
457
00:19:52,500 --> 00:19:53,760
Luckily for the patients,
458
00:19:53,760 --> 00:19:57,030
the sequences of those two animal insulins
459
00:19:57,030 --> 00:19:59,130
are very close to human insulin.
460
00:19:59,130 --> 00:20:02,580
So everyone got treated
and diabetes got treated.
461
00:20:02,580 --> 00:20:05,940
What Bill did is he took
his bachelor's degree
462
00:20:05,940 --> 00:20:08,250
in chemical engineering from Purdue,
463
00:20:08,250 --> 00:20:09,540
went to Lilly for a while
464
00:20:09,540 --> 00:20:12,450
and then went to Genentech in the Bay Area
465
00:20:12,450 --> 00:20:17,370
and figured out how to use
recombinant DNA technology
466
00:20:17,370 --> 00:20:21,000
to manufacture a fully human insulin.
467
00:20:21,000 --> 00:20:25,350
And that first fully human
insulin was called humulin.
468
00:20:25,350 --> 00:20:28,724
Now, you may know and your
listeners may know that
469
00:20:28,724 --> 00:20:30,960
and they may say, "Liz,
you know, wait a second.
470
00:20:30,960 --> 00:20:35,040
That's not true because the way
to make recombinant proteins
471
00:20:35,040 --> 00:20:36,450
was developed in the laboratory
472
00:20:36,450 --> 00:20:38,820
by people named Banning and Best.
473
00:20:38,820 --> 00:20:42,210
So that's the famous
recombinant DNA technology.
474
00:20:42,210 --> 00:20:44,310
But Bill Young and his
group were the first ones
475
00:20:44,310 --> 00:20:46,800
to figure out how to take that technology,
476
00:20:46,800 --> 00:20:48,840
that laboratory technology,
477
00:20:48,840 --> 00:20:51,960
and turn it into a manufacturing process
478
00:20:51,960 --> 00:20:54,870
that could make human insulin at scale.
479
00:20:54,870 --> 00:20:57,660
And it really started
the biotech revolution
480
00:20:57,660 --> 00:20:59,490
in the pharmaceutical industry.
481
00:20:59,490 --> 00:21:02,850
I tell that story in part
because what we wanna do
482
00:21:02,850 --> 00:21:06,120
as the Young Institute is
follow in Bill's footsteps.
483
00:21:06,120 --> 00:21:08,970
There are a lot of new
kinds of modalities,
484
00:21:08,970 --> 00:21:12,330
cell-based therapies, mRNA vaccines,
485
00:21:12,330 --> 00:21:15,720
gene therapies that are
coming into the laboratory
486
00:21:15,720 --> 00:21:18,330
and onto the market now,
487
00:21:18,330 --> 00:21:20,460
we want to invent really
488
00:21:20,460 --> 00:21:22,860
innovative manufacturing technologies
489
00:21:22,860 --> 00:21:26,160
that make these innovations
available to patients.
490
00:21:26,160 --> 00:21:27,330
So that's the dream.
491
00:21:27,330 --> 00:21:29,370
- Wow, what a dream it is.
492
00:21:29,370 --> 00:21:30,510
That's exciting.
493
00:21:30,510 --> 00:21:34,560
Let me turn to asking a question, Dr. Topp
494
00:21:34,560 --> 00:21:38,220
about your prior work at NIBRT in Dublin
495
00:21:38,220 --> 00:21:40,650
and how you are seeing parallels
496
00:21:40,650 --> 00:21:43,470
between what's happening in Ireland
497
00:21:43,470 --> 00:21:46,800
and what's happening in Indiana as well.
498
00:21:46,800 --> 00:21:49,320
And Dr. Alexeenko, you I understand,
499
00:21:49,320 --> 00:21:52,500
led a study abroad recently
to Ireland as well,
500
00:21:52,500 --> 00:21:55,230
exposing students to NIBRT
and what it's doing there.
501
00:21:55,230 --> 00:21:56,460
Would love to hear your thoughts
502
00:21:56,460 --> 00:21:59,430
on why Ireland and
Indiana Pharmaceuticals,
503
00:21:59,430 --> 00:22:00,750
what are the parallels?
504
00:22:00,750 --> 00:22:03,030
- It's a really
interesting question Arvind
505
00:22:03,030 --> 00:22:05,670
and Ireland is a world leader
506
00:22:05,670 --> 00:22:07,260
in pharmaceutical manufacturing.
507
00:22:07,260 --> 00:22:09,270
I think last time I checked
508
00:22:09,270 --> 00:22:11,580
it's one of the top five
509
00:22:11,580 --> 00:22:14,610
manufacturers of
pharmaceuticals in the world.
510
00:22:14,610 --> 00:22:17,790
And others include places like China
511
00:22:17,790 --> 00:22:20,670
that are thousands of times the size.
512
00:22:20,670 --> 00:22:23,010
And it's interesting for
me to draw the parallel,
513
00:22:23,010 --> 00:22:24,750
particularly with regard to size.
514
00:22:24,750 --> 00:22:28,410
Ireland is two thirds the size of Indiana,
515
00:22:28,410 --> 00:22:29,670
the Republic of Ireland,
516
00:22:29,670 --> 00:22:32,130
and about two thirds the population.
517
00:22:32,130 --> 00:22:36,090
And it has a similar sort
of combination of rural
518
00:22:36,090 --> 00:22:39,720
and manufacturing base to its economy.
519
00:22:39,720 --> 00:22:44,100
Ireland has managed to put
itself to the absolute forefront
520
00:22:44,100 --> 00:22:47,160
of pharmaceutical
manufacturing in the world.
521
00:22:47,160 --> 00:22:50,190
We are very proud in
Indiana that we rank first
522
00:22:50,190 --> 00:22:55,190
among the 50 states in
drug product exports
523
00:22:55,380 --> 00:22:57,480
that is outside of the state of Indiana,
524
00:22:57,480 --> 00:23:00,390
not not necessarily
outside of the country.
525
00:23:00,390 --> 00:23:02,580
The amount of pharmaceutical production
526
00:23:02,580 --> 00:23:06,780
from the Republic of Ireland
is five times what ours is.
527
00:23:06,780 --> 00:23:09,810
And so when I compare Indiana to Ireland,
528
00:23:09,810 --> 00:23:13,260
I think, well, we should
be and are justifiably
529
00:23:13,260 --> 00:23:15,930
proud of what we're doing here in Indiana.
530
00:23:15,930 --> 00:23:18,480
But you know, we're not Olympic league.
531
00:23:18,480 --> 00:23:21,150
We have a long way to go to catch Ireland
532
00:23:21,150 --> 00:23:24,240
to be able to manufacture at
the level that they're doing.
533
00:23:24,240 --> 00:23:25,440
- A lot of potential.
534
00:23:25,440 --> 00:23:28,440
- Lots of potential to
reach what they're doing.
535
00:23:28,440 --> 00:23:29,400
- Now, that's fascinating.
536
00:23:29,400 --> 00:23:32,910
And how was that trip with
students when they got to Ireland
537
00:23:32,910 --> 00:23:34,410
and see the pharmaceutical?
538
00:23:34,410 --> 00:23:35,520
- Oh, it was awesome.
539
00:23:35,520 --> 00:23:39,060
So we had two study
abroad groups actually.
540
00:23:39,060 --> 00:23:43,290
It was an excellent group of
students across the majors.
541
00:23:43,290 --> 00:23:47,640
So there was a mix of
students from engineering
542
00:23:47,640 --> 00:23:49,560
and various majors,
543
00:23:49,560 --> 00:23:51,870
chemical engineering,
mechanical engineering,
544
00:23:51,870 --> 00:23:53,910
and culture of pharmacy.
545
00:23:53,910 --> 00:23:57,600
We have a great pharmaceutical
sciences program
546
00:23:57,600 --> 00:24:00,900
and we had several pharm D students
547
00:24:00,900 --> 00:24:03,450
and we had a student from business school.
548
00:24:03,450 --> 00:24:06,210
So it was a college of
engineering study abroad,
549
00:24:06,210 --> 00:24:08,790
but taking a large group of students.
550
00:24:08,790 --> 00:24:13,740
And we've started at NIBRT,
551
00:24:13,740 --> 00:24:16,410
which was a great hands-on experience,
552
00:24:16,410 --> 00:24:20,040
and then went on a road
trip across Ireland
553
00:24:20,040 --> 00:24:21,600
to see drug product manufacturing
554
00:24:21,600 --> 00:24:24,150
as well as drug substance manufacturing.
555
00:24:24,150 --> 00:24:27,420
And I think our students
had a lot of ideas
556
00:24:27,420 --> 00:24:29,160
and had a lot of questions.
557
00:24:29,160 --> 00:24:31,860
And I hope that it kind
of generated for them
558
00:24:31,860 --> 00:24:34,320
a sense that there is a lot of opportunity
559
00:24:34,320 --> 00:24:36,153
in this area for innovation.
560
00:24:37,950 --> 00:24:42,780
It's not always easily
accessible area to innovate.
561
00:24:42,780 --> 00:24:47,663
I hope that this has expanded
sort of beyond the classroom
562
00:24:47,663 --> 00:24:50,400
reach of their imagination.
563
00:24:50,400 --> 00:24:52,290
- Well, and it hopefully helps
564
00:24:52,290 --> 00:24:55,080
some of these amazing talented students,
565
00:24:55,080 --> 00:24:58,950
you know, consider what could be a career
566
00:24:58,950 --> 00:25:01,950
where you literally save,
567
00:25:01,950 --> 00:25:04,950
the job is to save as
many lives as possible.
568
00:25:04,950 --> 00:25:07,080
- Yeah, actually many-
- How cool would that be?
569
00:25:07,080 --> 00:25:09,870
- Many of them have accepted internships
570
00:25:09,870 --> 00:25:13,050
and some of them even
already full-time jobs
571
00:25:13,050 --> 00:25:15,450
and some of them in Indiana.
572
00:25:15,450 --> 00:25:17,160
- Oh, that is-
573
00:25:17,160 --> 00:25:18,870
- I just wanna comment too from the,
574
00:25:18,870 --> 00:25:20,400
now from the Irish perspective,
575
00:25:20,400 --> 00:25:22,590
that what Alina and her group did
576
00:25:22,590 --> 00:25:24,660
was over two different years
577
00:25:24,660 --> 00:25:28,620
take a group of Purdue
students to Dublin, Ireland
578
00:25:28,620 --> 00:25:31,680
and elsewhere over St. Patrick's Day week,
579
00:25:31,680 --> 00:25:33,660
which was a brave thing
to do in the first place.
580
00:25:33,660 --> 00:25:36,000
And the students did us proud.
581
00:25:36,000 --> 00:25:38,250
I think there's, at NIBRT anyway,
582
00:25:38,250 --> 00:25:40,530
there's a sense that this
was a fine group of students
583
00:25:40,530 --> 00:25:42,840
who comported themselves wonderfully,
584
00:25:42,840 --> 00:25:45,780
and they didn't act like
it was spring break,
585
00:25:45,780 --> 00:25:47,430
you know, kids gone wild.
586
00:25:47,430 --> 00:25:48,660
They were just wonderful
587
00:25:48,660 --> 00:25:51,060
and so they've made a
very good impression.
588
00:25:51,060 --> 00:25:53,400
- It's the Purdue quality
students, you know.
589
00:25:53,400 --> 00:25:54,750
That's fantastic to hear.
590
00:25:54,750 --> 00:25:57,060
I did want to take a little break
591
00:25:57,060 --> 00:25:59,070
from some of the technical details here
592
00:25:59,070 --> 00:26:02,010
and try to understand
your own personal journeys
593
00:26:02,010 --> 00:26:04,770
to this pharmaceutical and biotech,
594
00:26:04,770 --> 00:26:06,840
almost futuristic land as I think about
595
00:26:06,840 --> 00:26:08,370
what you're all doing.
596
00:26:08,370 --> 00:26:10,320
Dr. Topp maybe starting with you,
597
00:26:10,320 --> 00:26:12,120
like how did this come into,
598
00:26:12,120 --> 00:26:13,470
like this is what you wanted to do
599
00:26:13,470 --> 00:26:14,460
and dedicated your life to?
600
00:26:14,460 --> 00:26:15,330
How did that happen?
601
00:26:15,330 --> 00:26:17,070
- Yeah, it's a great question, Arvind,
602
00:26:17,070 --> 00:26:18,480
and you and I kind of had a little
603
00:26:18,480 --> 00:26:21,420
sidebar conversation before the podcast.
604
00:26:21,420 --> 00:26:23,820
When I was in my teens,
605
00:26:23,820 --> 00:26:26,520
I was diagnosed with what was then called
606
00:26:26,520 --> 00:26:29,760
minor idiopathic motor seizures,
607
00:26:29,760 --> 00:26:34,710
which would now be called JME,
Juvenile Myoclonic Epilepsy.
608
00:26:34,710 --> 00:26:37,230
So I was diagnosed as
an epileptic in my teens
609
00:26:37,230 --> 00:26:40,410
and started being medicated
with anticonvulsants
610
00:26:40,410 --> 00:26:43,320
when I was 16, 17, something like that.
611
00:26:43,320 --> 00:26:45,480
And as is typical for teenagers,
612
00:26:45,480 --> 00:26:47,460
I didn't really want to have this
613
00:26:47,460 --> 00:26:50,160
and I didn't really want
to take these medications.
614
00:26:50,160 --> 00:26:52,230
But it instilled in me a fascination
615
00:26:52,230 --> 00:26:55,050
with what drugs are and how they work
616
00:26:55,050 --> 00:26:58,680
and maybe how we could understand
them and make them better.
617
00:26:58,680 --> 00:27:01,020
I didn't like the side
effects of those medications
618
00:27:01,020 --> 00:27:02,640
and I didn't wanna have to take them.
619
00:27:02,640 --> 00:27:05,530
So I think that's stayed
with me all these years
620
00:27:05,530 --> 00:27:08,100
and been an inspiration for how we might
621
00:27:08,100 --> 00:27:09,660
make pharmaceuticals better.
622
00:27:09,660 --> 00:27:11,640
- So the bitter taste left in your mouth
623
00:27:11,640 --> 00:27:16,290
actually led to this amazing
revolution happening today.
624
00:27:16,290 --> 00:27:17,613
That's great.
- Yeah.
625
00:27:18,510 --> 00:27:20,190
- Dr. Alexeenko, I mean,
626
00:27:20,190 --> 00:27:23,670
you were until recently
full-time professor
627
00:27:23,670 --> 00:27:25,860
in the School of Aeronautics
and Astronautics at Purdue,
628
00:27:25,860 --> 00:27:28,710
and then you got interested in this space
629
00:27:28,710 --> 00:27:30,750
and like how does your background
630
00:27:30,750 --> 00:27:32,520
in aeronautics and astronautics
631
00:27:32,520 --> 00:27:34,320
and now you've got a joint appointment
632
00:27:34,320 --> 00:27:36,030
with chemical engineering,
633
00:27:36,030 --> 00:27:39,873
what's the connection between
Aeroastro and pharmaceuticals?
634
00:27:40,800 --> 00:27:44,940
- So actually these are my
two professional passions
635
00:27:44,940 --> 00:27:47,820
is space and medicine.
636
00:27:47,820 --> 00:27:49,590
And so my mom is a doctor,
637
00:27:49,590 --> 00:27:53,100
so I had this big fork
in the road where to go
638
00:27:53,100 --> 00:27:55,080
called, you know, math,
639
00:27:55,080 --> 00:27:58,230
science, engineering or medical school.
640
00:27:58,230 --> 00:28:01,083
And I actually applied and
I got admitted to both.
641
00:28:02,100 --> 00:28:04,863
And at some point I didn't
go to medical school.
642
00:28:06,000 --> 00:28:09,300
I volunteered, I worked during summers.
643
00:28:09,300 --> 00:28:12,213
I was intending to become
a doctor like my mom.
644
00:28:13,320 --> 00:28:14,153
- A real doctor.
645
00:28:14,153 --> 00:28:15,900
- A real doctor, yeah.
646
00:28:15,900 --> 00:28:18,900
But space has this attractive power.
647
00:28:18,900 --> 00:28:21,273
I grew up under Polish EUs
648
00:28:21,273 --> 00:28:22,680
first international docking in space
649
00:28:22,680 --> 00:28:26,400
and those marvels of ages,
650
00:28:26,400 --> 00:28:29,280
and somehow through the magic of Purdue,
651
00:28:29,280 --> 00:28:32,820
actually I'm kind of getting
to where I wanted this,
652
00:28:32,820 --> 00:28:35,160
making medicines in space.
653
00:28:35,160 --> 00:28:39,120
And we can talk about this.
654
00:28:39,120 --> 00:28:41,400
- Well, I
mean it's
fascinating to hear that
655
00:28:41,400 --> 00:28:43,410
that journey in your case,
656
00:28:43,410 --> 00:28:45,480
not a straight path,
657
00:28:45,480 --> 00:28:47,937
but you got to where you
were always interested
658
00:28:47,937 --> 00:28:51,150
and you got a way to combine
those two passions in one.
659
00:28:51,150 --> 00:28:53,640
- Well, I think there's
a backstory here too
660
00:28:53,640 --> 00:28:55,590
that's really interesting in that,
661
00:28:55,590 --> 00:28:57,900
lyophilization is freeze-drying
662
00:28:57,900 --> 00:28:59,626
and you think of course
of cold temperatures.
663
00:28:59,626 --> 00:29:00,459
- Right?
664
00:29:00,459 --> 00:29:02,280
- But it's also done at low pressure.
665
00:29:02,280 --> 00:29:03,113
- Right?
666
00:29:03,113 --> 00:29:04,410
- And so the fluid flow regimes
667
00:29:04,410 --> 00:29:06,510
in pharmaceutical lyophilization
668
00:29:06,510 --> 00:29:10,290
and for rocket propulsion in
outer space are very similar.
669
00:29:10,290 --> 00:29:14,040
And so Alina actually,
and Lyo had at one point
670
00:29:14,040 --> 00:29:17,370
a T-shirt that in wonderful graphics said,
671
00:29:17,370 --> 00:29:19,860
lyophilization is rocket science, right?
672
00:29:19,860 --> 00:29:22,767
Because the fluid mechanics
for lyophilization
673
00:29:22,767 --> 00:29:26,340
and the fluid mechanics
for rockets in outer space
674
00:29:26,340 --> 00:29:27,580
have a lot in common.
675
00:29:27,580 --> 00:29:28,479
- Oh my goodness.
676
00:29:28,479 --> 00:29:30,420
One would not have thought of that at all.
677
00:29:30,420 --> 00:29:33,390
- Yeah, so actually that started
678
00:29:33,390 --> 00:29:34,800
that at some point I got an email
679
00:29:34,800 --> 00:29:36,990
from an engineer in Netherlands
680
00:29:36,990 --> 00:29:41,790
using one of our very
aerospace modeling tools
681
00:29:41,790 --> 00:29:43,543
and started asking questions about
682
00:29:43,543 --> 00:29:46,786
a state that is very
strange for water vapor.
683
00:29:46,786 --> 00:29:48,900
And, you know, I started asking why.
684
00:29:48,900 --> 00:29:53,160
And that led to freeze-drying research.
685
00:29:53,160 --> 00:29:55,980
And yes, as Liz said,
686
00:29:55,980 --> 00:29:59,160
freeze-drying happens in
a space like environment.
687
00:29:59,160 --> 00:30:04,050
The typical pressures,
infra drying chambers,
688
00:30:04,050 --> 00:30:06,063
are around 80 kilometer of earth.
689
00:30:07,546 --> 00:30:08,500
- The distance from the surface, right?
690
00:30:08,500 --> 00:30:11,490
- Yeah, so that's exactly
the edge of space.
691
00:30:11,490 --> 00:30:12,323
- Right?
692
00:30:12,323 --> 00:30:14,820
- That's where rockets take spacecraft.
693
00:30:14,820 --> 00:30:17,310
So a lot of modeling and sensing tools
694
00:30:17,310 --> 00:30:19,500
that have been originally developed
695
00:30:19,500 --> 00:30:22,740
by aerospace community
for space applications
696
00:30:22,740 --> 00:30:25,410
are ideally suited to
innovate
697
00:30:25,410 --> 00:30:27,810
in pharmaceutical manufacturing space.
698
00:30:27,810 --> 00:30:29,640
And, you know, thinking more broadly,
699
00:30:29,640 --> 00:30:32,070
I believe the future of
pharmaceutical manufacturing
700
00:30:32,070 --> 00:30:33,330
is in space.
701
00:30:33,330 --> 00:30:35,250
There's a number of good reasons.
702
00:30:35,250 --> 00:30:39,270
So one of them I never mentioned,
stability and sterility.
703
00:30:39,270 --> 00:30:43,500
So here on earth we spend
a lot of effort and years
704
00:30:43,500 --> 00:30:47,670
and billions of dollars
building this large clean rooms
705
00:30:47,670 --> 00:30:50,973
and maintaining extremely
clean environment.
706
00:30:52,549 --> 00:30:55,260
- Which is already there.
- Space is vast clean room.
707
00:30:55,260 --> 00:30:56,310
There is no gravity.
708
00:30:56,310 --> 00:30:58,440
Gravity complicates a
lot of things on earth
709
00:30:58,440 --> 00:31:01,650
by introducing graduates
in density for example,
710
00:31:01,650 --> 00:31:03,630
from cryo concentration
711
00:31:03,630 --> 00:31:08,310
and therefore loss of stability
of proteins during freezing
712
00:31:08,310 --> 00:31:10,230
happens because of gravity.
713
00:31:10,230 --> 00:31:13,287
Minus the gravity,
everything would be uniform.
714
00:31:13,287 --> 00:31:14,667
- Wow.
715
00:31:14,667 --> 00:31:15,960
- And so that's gravity.
716
00:31:15,960 --> 00:31:17,940
There is also other, you know,
717
00:31:17,940 --> 00:31:19,350
there is always a source of heat.
718
00:31:19,350 --> 00:31:20,463
You look at the sun,
719
00:31:21,420 --> 00:31:25,020
you have about a kilowatt
per square to heat source,
720
00:31:25,020 --> 00:31:26,280
you look away from the sun,
721
00:31:26,280 --> 00:31:28,530
you have a very cold background.
722
00:31:28,530 --> 00:31:29,520
So there is a...
723
00:31:29,520 --> 00:31:30,870
But if you think about it,
724
00:31:30,870 --> 00:31:33,810
if we go back to the
supply chain discussion
725
00:31:33,810 --> 00:31:37,350
that it's often involves
multiple continents.
726
00:31:37,350 --> 00:31:41,010
What is one location that's
two hours driving distance
727
00:31:41,010 --> 00:31:42,393
from anywhere on earth?
728
00:31:43,890 --> 00:31:44,723
- Up there.
729
00:31:44,723 --> 00:31:46,073
- Yeah, lower earth orbit.
730
00:31:46,073 --> 00:31:47,430
(all laughing)
731
00:31:47,430 --> 00:31:50,100
- Well, and Arvind I
hope your listeners will,
732
00:31:50,100 --> 00:31:51,900
especially the engineering alums
733
00:31:51,900 --> 00:31:55,680
and the aspiring engineers
will take from this that,
734
00:31:55,680 --> 00:31:57,990
one of the beautiful
things about engineering
735
00:31:57,990 --> 00:31:59,970
is how the fundamental understanding
736
00:31:59,970 --> 00:32:02,580
sort of spans different applications.
737
00:32:02,580 --> 00:32:05,850
And so what Alina understands
about fluid mechanics
738
00:32:05,850 --> 00:32:08,730
in sort of rarefied atmospheres
739
00:32:08,730 --> 00:32:12,270
applies to what's happening
for rockets in space
740
00:32:12,270 --> 00:32:16,020
and applies to pharmaceutical
lyophilization equally well.
741
00:32:16,020 --> 00:32:17,640
Right, and so I think that's just
742
00:32:17,640 --> 00:32:20,040
such a magic thing about engineering.
743
00:32:20,040 --> 00:32:23,910
- It's wonderful and amazing to hear about
744
00:32:23,910 --> 00:32:26,880
all the innovations that
both of you're involved in
745
00:32:26,880 --> 00:32:30,810
and to hear that the supply
chain for pharmaceuticals
746
00:32:30,810 --> 00:32:32,640
is not just global,
747
00:32:32,640 --> 00:32:34,364
it could be intergalactic one day.
748
00:32:34,364 --> 00:32:35,197
- Yeah.
749
00:32:35,197 --> 00:32:38,667
- We are on the cusp of
making this a reality.
750
00:32:38,667 --> 00:32:40,950
We, meaning the global we,
751
00:32:40,950 --> 00:32:45,000
which includes very
closely Purdue community.
752
00:32:45,000 --> 00:32:48,450
So one of our colleagues
in college of pharmacy,
753
00:32:48,450 --> 00:32:50,640
Steve Byrne and his
company Improved Pharma,
754
00:32:50,640 --> 00:32:53,710
recently collaborated with a space startup
755
00:32:54,905 --> 00:32:59,905
about space industries on first stable,
756
00:33:00,552 --> 00:33:03,450
manufacturing of stable Ritonavir
757
00:33:03,450 --> 00:33:06,540
and multiple polymers of that,
758
00:33:06,540 --> 00:33:10,620
including some that are very
difficult to obtain on earth.
759
00:33:10,620 --> 00:33:13,950
And Ritonavir is a HIV drug.
760
00:33:13,950 --> 00:33:16,350
Just in March this year,
761
00:33:16,350 --> 00:33:18,730
they brought it back to Earth
762
00:33:19,710 --> 00:33:22,260
and it's actually, the
sample is in West Lafayette
763
00:33:22,260 --> 00:33:24,930
and there will be
publications coming out of it.
764
00:33:24,930 --> 00:33:25,929
- Oh my goodness.
765
00:33:25,929 --> 00:33:28,323
- So for your listeners
to look up about that,
766
00:33:29,220 --> 00:33:32,703
Improved Pharma, "Return
of the Ritonavir".
767
00:33:33,824 --> 00:33:35,010
- "Return of the Ritonavir".
768
00:33:35,010 --> 00:33:37,740
Oh my goodness, that's amazing.
769
00:33:37,740 --> 00:33:39,450
To learn more about advanced
770
00:33:39,450 --> 00:33:41,100
manufacturing of Pharmaceuticals,
771
00:33:41,100 --> 00:33:46,100
please visit
younginstitute.research.purdue.edu.
772
00:33:48,000 --> 00:33:49,620
This is Arvind Raman,
773
00:33:49,620 --> 00:33:52,347
signing off this episode of "Engenuity".
774
00:33:53,520 --> 00:33:55,260
- This has been "Engenuity",
775
00:33:55,260 --> 00:33:57,600
a Boilermaker Engineering Podcast.
776
00:33:57,600 --> 00:33:59,490
For more information on some of the issues
777
00:33:59,490 --> 00:34:01,230
discussed in this podcast,
778
00:34:01,230 --> 00:34:03,060
go to the engineering homepage
779
00:34:03,060 --> 00:34:05,724
and click on the podcast
icon on the upper right.
780
00:34:05,724 --> 00:34:08,307
(gentle music)